Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

A randomized, open-label, dose-response study of losartan in hypertensive children.

Webb NJ, Wells TG, Shahinfar S, Massaad R, Dankner WM, Lam C, Santoro EP, McCrary Sisk C, Blaustein RO.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1441-8. doi: 10.2215/CJN.11111113. Epub 2014 May 29.

2.

Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.

Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, Van Dyke RB; Pediatric AIDS Clinical Trials Group219/219C Team.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94. doi: 10.1097/QAI.0b013e3181b9869f.

3.

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.

Weinberg A, Huang S, Fenton T, Patterson-Bartlett J, Gona P, Read JS, Dankner WM, Nachman S; IMPAACT P1008 Team.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):17-24. doi: 10.1097/QAI.0b013e3181b011f6.

4.

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team.

Arch Pediatr Adolesc Med. 2009 Feb;163(2):164-71. doi: 10.1001/archpedi.163.2.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Apr;163(4):364.

5.

The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection.

Seage GR 3rd, Buchacz K, Weinberg GA, Patel K, McIntosh K, Dankner WM.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):603-10.

PMID:
17003692
6.

Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.

Patel K, Weinberg GA, Buchacz K, McIntosh K, Dankner WM, Seage GR 3rd.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):611-7.

PMID:
17003691
7.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR 3rd.

JAMA. 2006 Jul 19;296(3):292-300.

PMID:
16849662
8.

Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

Hughes WT, Dankner WM, Yogev R, Huang S, Paul ME, Flores MA, Kline MW, Wei LJ; Pediatric AIDS Clinical Trials Group 254 Team.

Clin Infect Dis. 2005 Jan 1;40(1):136-45. Epub 2004 Dec 6.

PMID:
15614703
9.

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents.

Soh CH, Oleske JM, Brady MT, Spector SA, Borkowsky W, Burchett SK, Foca MD, Handelsman E, Jiménez E, Dankner WM, Hughes MD; Pediatric AIDS Clinical Trials Group.

Lancet. 2003 Dec 20;362(9401):2045-51.

PMID:
14697803
10.

Pharmacokinetics and tolerance of zidovudine in preterm infants.

Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, Gay H, Ciupak G, Smith B, Connor JD; Pediatric AIDS Clinical Trials Group 331 Investigators.

J Pediatr. 2003 Jan;142(1):47-52.

PMID:
12520254
11.

Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR 3rd, Song LY, Dankner WM, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

N Engl J Med. 2001 Nov 22;345(21):1522-8.

12.

Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.

Buchacz K, Cervia JS, Lindsey JC, Hughes MD, Seage GR 3rd, Dankner WM, Oleske JM, Moye J.

Pediatrics. 2001 Oct;108(4):E72.

PMID:
11581480
13.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Dankner WM, Lindsey JC, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327.

Pediatr Infect Dis J. 2001 Jan;20(1):40-8.

PMID:
11176565
14.

Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group.

Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, Culnane M, Read JS, Thompson M, Mohan KM, Shaver A, Robinson CA, Stempien MJ, Burchett SK, Melvin AJ, Borkowsky W, Petru A, Kovacs A, Yogev R, Goldsmith J, McFarland EJ, Spector SA.

J Infect Dis. 2000 Dec;182(6):1616-24. Epub 2000 Nov 8.

PMID:
11069232
15.

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.

Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, Spector SA, Chadwick EG.

Pediatrics. 2000 Jun;105(6):E80.

PMID:
10835093
17.

Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.

King JC Jr, Borkowsky W, Mahidhara N, Madore D, Shapiro ED, Rutstein RM, Tan TQ, Farley JJ, Dankner WM, Nachman S, Simoes E, Flynn PM, Clemens J, Hamilton RG.

J Infect Dis. 2000 May;181(5):1817-21. Epub 2000 May 15.

PMID:
10823792
18.

Nosocomial transmission of Mycobacterium bovis bacille Calmette-Guerin to children receiving cancer therapy and to their health care providers.

Waecker NJ Jr, Stefanova R, Cave MD, Davis CE, Dankner WM.

Clin Infect Dis. 2000 Feb;30(2):356-62.

PMID:
10671341
19.

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.

Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage RC, Manion D, Ruiz N, Gersten M, Becker M, McNamara J, Mofenson LM, Purdue L, Siminski S, Graham B, Kornhauser DM, Fiske W, Vincent C, Lischner HW, Dankner WM, Flynn PM.

N Engl J Med. 1999 Dec 16;341(25):1874-81.

20.

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.

Viani RM, Dankner WM, Muelenaer PA, Spector SA.

Pediatrics. 1999 Dec;104(6):1394-6. Review.

PMID:
10585995
21.

Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team.

Ngo LY, Yogev R, Dankner WM, Hughes WT, Burchett S, Xu J, Sadler B, Unadkat JD.

Antimicrob Agents Chemother. 1999 Jun;43(6):1516-9.

22.

A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.

Kline MW, Blanchard S, Fletcher CV, Shenep JL, McKinney RE Jr, Brundage RC, Culnane M, Van Dyke RB, Dankner WM, Kovacs A, McDowell JA, Hetherington S.

Pediatrics. 1999 Apr;103(4):e47.

PMID:
10103339
23.

Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection.

Swanson DS, Pan X, Kline MW, McKinney RE Jr, Yogev R, Lewis LL, Brady MT, McSherry GD, Dankner WM, Musser JM.

J Infect Dis. 1998 Sep;178(3):776-82.

PMID:
9728547
24.

Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group.

Spector SA, Blanchard S, Wara DW, Oleske JM, McIntosh K, Hodes D, Dankner WM, Salgo M, McNamara J.

Pediatr Infect Dis J. 1997 Jun;16(6):623-6. No abstract available.

PMID:
9194115
25.

Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children.

Pratt RD, Nichols S, McKinney N, Kwok S, Dankner WM, Spector SA.

J Infect Dis. 1996 Aug;174(2):288-93.

PMID:
8699057
26.

Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.

Plotkin SA, Higgins R, Kurtz JB, Morris PJ, Campbell DA Jr, Shope TC, Spector SA, Dankner WM.

Transplantation. 1994 Dec 15;58(11):1176-8.

PMID:
7992358
27.
28.

Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.

Spencer LT, Ogino MT, Dankner WM, Spector SA.

J Infect Dis. 1994 Mar;169(3):491-5.

PMID:
7908924
29.
30.

Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.

Flores-Aguilar M, Kuppermann BD, Quiceno JI, Dankner WM, Wolf DG, Capparelli EV, Connor JD, Sherwood CH, Fullerton S, Gambertoglio JG, et al.

Ophthalmology. 1993 Jul;100(7):1022-31.

PMID:
8391674
31.
32.

Pediatric human immunodeficiency virus infection in a low seroprevalence area.

Pratt RD, Hatch R, Dankner WM, Spector SA.

Pediatr Infect Dis J. 1993 Apr;12(4):304-10.

PMID:
8483625
33.

Hepatitis B in a prenatal population.

Dankner WM, Dixon SD, Lane TA, Moore T.

JAMA. 1993 Feb 3;269(5):589-90. No abstract available.

PMID:
8421360
34.

Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen.

Dankner WM, Waecker NJ, Essey MA, Moser K, Thompson M, Davis CE.

Medicine (Baltimore). 1993 Jan;72(1):11-37. Review.

PMID:
8426535
35.

Meningococcal disease in a pediatric population in San Diego County.

Dankner WM, Ginsberg MM, Davis CE.

Pediatr Infect Dis J. 1993 Jan;12(1):98-9. No abstract available.

PMID:
8292104
36.

Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification.

Spector SA, Merrill R, Wolf D, Dankner WM.

J Clin Microbiol. 1992 Sep;30(9):2359-65.

37.

Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.

Dankner WM, Scholl D, Stanat SC, Martin M, Sonke RL, Spector SA.

J Virol Methods. 1990 Jun;28(3):293-8.

PMID:
2166749
38.

Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.

Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA.

J Infect Dis. 1990 Jan;161(1):31-6.

PMID:
2153186
40.

Treatment of bacterial meningitis with once daily ceftriaxone therapy.

Dankner WM, Connor JD, Sawyer M, Straube R, Spector SA.

J Antimicrob Chemother. 1988 May;21(5):637-45.

PMID:
3391863
41.

DF-2 bacteremia following a dog bite in a 4-month-old child.

Dankner WM, Davis CE, Thompson MA.

Pediatr Infect Dis J. 1987 Jul;6(7):695-6. No abstract available.

PMID:
3615084
42.

Malassezia fungemia in neonates and adults: complication of hyperalimentation.

Dankner WM, Spector SA, Fierer J, Davis CE.

Rev Infect Dis. 1987 Jul-Aug;9(4):743-53. Review.

PMID:
3125578
43.

Peroxidase-antiperoxidase assay for rapid detection of respiratory syncytial virus in nasal epithelial specimens from infants and children.

Jalowayski AA, England BL, Temm CJ, Nunemacher TJ, Bastian JF, MacPherson GA, Dankner WM, Straube RC, Connor JD.

J Clin Microbiol. 1987 Apr;25(4):722-5.

44.

Recurrent herpes simplex in a neonate.

Dankner WM, Spector SA.

Pediatr Infect Dis. 1986 Sep-Oct;5(5):582-6. No abstract available.

PMID:
3020520
45.

Rapid viral diagnostic techniques.

Spector SA, Dankner WM.

Adv Pediatr Infect Dis. 1986;1:37-59. Review.

PMID:
3331277
46.

Malasezzia furfur sepsis in neonates.

Dankner WM, Spector SA.

J Pediatr. 1985 Oct;107(4):643-4. No abstract available.

PMID:
4045616

Supplemental Content

Loading ...
Support Center